Observe Medical ASA: Notice of extraordinary general meeting on 7 January 2025 in connection with reverse share split

17 Dec 2024 13:25 CET

Oslo, 17 December 2024

An extraordinary general meeting of Observe Medical ASA ("Observe Medical" or
the "Company", OSE ticker: OBSVR) will be held on 7 January 2025 at 10:00 (CET).
The notice of the extraordinary general meeting, including agenda, proposed
resolutions, registration form, a form of proxy and other relevant documents, is
enclosed hereto.

The agenda includes a proposal for a consolidation of the Company's shares
(reverse share split), in the ratio 15:1, to meet the Oslo Stock Exchange's
requirement of a minimum market value of NOK 1 per share.

To facilitate the share consolidation, the board of directors also proposes a
small increase of the Company's share capital by NOK 1.30, through the issue of
5 new shares, each with a nominal value of NOK 0.26, in order to obtain a total
number of shares divisible by 15.

Provided that the share consolidation is resolved by the general meeting, the
Company will issue a separate stock exchange announcement with the key dates for
the share consolidation once such dates have been determined.

Reference is made to the notice of the extraordinary general meeting for further
information about the above-mentioned proposals, as well as the other items on
the agenda.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

More information:
Access the news on Oslo Bors NewsWeb site

634946_Notice_of_extraordinary_general_meeting_on_7_January_2025_in_connection_with_reverse_share_split.pdf